Back
Phathom Pharmaceuticals Vs. ArcBest Industry Stock Comparison
Buy
78
PHAT
Phathom Pharmaceuticals
Last Price:
10.71
Seasonality Move:
-9.38%
Buy
56
ARCB
ArcBest
Last Price:
115.23
Seasonality Move:
8.51%
Buy
78
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $10.41. The Score for PHAT is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
ArcBest (ARCB)
is a Buy
Is ArcBest a Buy, Sell or Hold?
- The current ArcBest [ARCB] share price is $117.83. The Score for ARCB is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ARCB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $10.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing slight buying pressure.
ARCB Stock Price Chart
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 56.38 | Buy |
| Chaikin Money Flow: | 23052 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.19 - 10.27) | Buy |
| Bollinger Bands (100): | (7.63 - 10.43) | Buy |
ARCB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.93 | Sell |
| Relative Strength Index (14 RSI): | 40.58 | Sell |
| Chaikin Money Flow: | -111908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.63 - 142.69) | Sell |
| Bollinger Bands (100): | (119.23 - 142.81) | Sell |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.16 | Buy |
| 20-day SMA: | 9.63 | Buy |
| 50-day SMA: | 9.75 | Buy |
| 200-day SMA: | 9.86 | Buy |
| 8-day EMA: | 10.06 | Buy |
| 20-day EMA: | 9.91 | Buy |
| 50-day EMA: | 9.69 | Buy |
| 200-day EMA: | 9.74 | Buy |
ARCB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 117.16 | Buy |
| 20-day SMA: | 123.83 | Sell |
| 50-day SMA: | 133.65 | Sell |
| 200-day SMA: | 119.37 | Sell |
| 8-day EMA: | 118.01 | Sell |
| 20-day EMA: | 123.22 | Sell |
| 50-day EMA: | 129.5 | Sell |
| 200-day EMA: | 120.65 | Sell |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.34 per share, a decrease this year of $1.15 per share, and an increase next year of $1.18 per share.
ArcBest Earnings Growth & ARCB Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.18 per share, an increase next quarter of $0.15 per share, an increase this year of $0.97 per share, and an increase next year of $2.59 per share.
Phathom Pharmaceuticals Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ArcBest Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||